Emergent BioSolutions Inc. - EBS
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | SVP, Products Business | S | D | 3,000.0 | 8.4 | 25,200.0 | 159,098.0 | View | |
| Jun 10, 2026 | SVP, Products Business | F | D | 694.0 | 8.0 | 5,552.0 | 162,098.0 | View | |
| Jun 10, 2026 | EVP, Chief Financial Officer | F | D | 3,964.0 | 8.0 | 31,712.0 | 374,083.0 | View | |
| Jun 10, 2026 | EVP, Quality & Ethics, and CPL | F | D | 2,018.0 | 8.0 | 16,144.0 | 202,201.0 | View | |
| Jun 10, 2026 | SVP, Bioservices | F | D | 1,741.0 | 8.0 | 13,928.0 | 185,558.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | S | D | 954.0 | 8.96 | 8,547.84 | 129,721.0 | View | |
| May 04, 2026 | — | S | D | 14,527.0 | 8.36 | 121,445.72 | 130,675.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 145,202.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | S | D | 980.0 | 8.94 | 8,761.2 | 100,563.0 | View | |
| May 04, 2026 | — | S | D | 12,781.0 | 8.36 | 106,849.16 | 101,543.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 114,324.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 113,839.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | S | D | 15,481.0 | 8.28 | 128,182.68 | 96,294.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 111,775.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 30,350.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 123,761.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | S | D | 1,057.0 | 8.97 | 9,481.29 | 79,941.0 | View | |
| May 04, 2026 | — | S | D | 16,145.0 | 8.36 | 134,972.2 | 80,998.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 97,143.0 | View | |
| May 04, 2026 | — | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | — | A | A | 25,344.0 | 0.0 | 0.0 | 160,847.0 | View | |
| May 04, 2026 | Chairman | A | A | 11,296.0 | 0.0 | 0.0 | 11,296.0 | View | |
| May 04, 2026 | Chairman | A | A | 25,344.0 | 0.0 | 0.0 | 149,076.0 | View | |
| May 01, 2026 | SVP, R&D, CMO | A | A | 100,111.0 | 0.0 | 0.0 | 177,914.0 | View | |
| May 01, 2026 | SVP, Products Business | A | A | 100,111.0 | 0.0 | 0.0 | 162,792.0 | View | |
| May 01, 2026 | EVP, Quality & Ethics, and CPL | A | A | 100,111.0 | 0.0 | 0.0 | 204,219.0 | View | |
| May 01, 2026 | EVP, Chief Financial Officer | A | A | 162,680.0 | 0.0 | 0.0 | 378,047.0 | View | |
| May 01, 2026 | SVP, General Counsel, Corp Sec | A | A | 104,282.0 | 0.0 | 0.0 | 165,286.0 | View | |
| May 01, 2026 | SVP, Bioservices | A | A | 100,111.0 | 0.0 | 0.0 | 187,299.0 | View | |
| May 01, 2026 | President and CEO | A | A | 187,708.0 | 0.0 | 0.0 | 493,153.0 | View | |
| Apr 03, 2026 | SVP, Products Business | S | D | 4,000.0 | 8.44 | 33,760.0 | 62,681.0 | View |